Interaction of substrates and inhibitors with the enoyl reductase enzymes from E. coli (FabI) and M. tuberculosis (InhA)

被引:0
|
作者
Tonge, PJ
Sullivan, T
Novichenok, P
Truglio, J
Subramanta, K
Kisker, C
Johnson, F
Slayden, R
机构
[1] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA
[2] SUNY Stony Brook, Ctr Struct Biol, Stony Brook, NY 11794 USA
[3] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA
[4] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA
来源
FASEB JOURNAL | 2005年 / 19卷 / 05期
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:A1389 / A1389
页数:1
相关论文
共 32 条
  • [1] Interacting AcpM with InhA, the enoyl-ACP reductase from M. tuberculosis
    Zhang, Xujie
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232 : 848 - 848
  • [2] Novel inhibitors of InhA, the enoyl reductase from mycobacterium tuberculosis.
    Tonge, PJ
    Sullivan, TJ
    Novichenok, P
    Truglio, JJ
    Kisker, C
    Johnson, F
    Slayden, RA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U164 - U164
  • [3] Spiro-naphthyridinone piperidines as inhibitors of S. aureus and E. coli enoyl-ACP reductase (FabI)
    Sampson, Peter B.
    Picard, Christine
    Handerson, Sean
    McGrath, Teresa E.
    Domagala, Megan
    Leeson, Andrew
    Romanov, Vladimir
    Awrey, Donald E.
    Thambipillai, Dhushy
    Bardouniotis, Elias
    Kaplan, Nachum
    Berman, Judd M.
    Pauls, Henry W.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (18) : 5355 - 5358
  • [4] Design, docking, synthesis and anti E. coli screening of novel thiadiazolo thiourea derivatives as possible inhibitors of Enoyl ACP reductase (FabI) enzyme
    George, Sonia
    Basheer, Ramzeena Mohammed
    Ram, Sayee Vignesh
    Selvaraj, Senthil Kumar
    Rajan, Shinu
    Ravi, Thengungal Kochupappy
    BANGLADESH JOURNAL OF PHARMACOLOGY, 2014, 9 (01) : 49 - 53
  • [5] Novel enoyl-ACP reductase (FabI) potential inhibitors of Escherichia coli from Chinese medicine monomers
    Yao, Jingjing
    Zhang, Qingye
    Min, Jun
    He, Jin
    Yu, Ziniu
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) : 56 - 59
  • [6] Developing novel inhibitors of the enoyl reductase from mycobacterium tuberculosis (INHA) : SAR studies of triclosan congeners.
    Sullivan, TJ
    Novichenok, P
    Truglio, JJ
    Kisker, C
    Johnson, F
    Slayden, RA
    Tonge, PJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U176 - U176
  • [7] Rational approach in the new antituberculosis agent design:: inhibitors of InhA, the enoyl-ACP reductase from Mycobacterium tuberculosis
    Andrade, Carolina Horta
    Mesquita Pasqualoto, Kerly Fernanda
    Zaim, Marcio Henrique
    Ferreira, Elizabeth Igne
    REVISTA BRASILEIRA DE CIENCIAS FARMACEUTICAS, 2008, 44 (02): : 167 - 179
  • [8] A comparison of the dynamics of Pantothenate Synthetase from M. tuberculosis and E. coli: Computational studies
    Tan, Yaw Sing
    Fuentes, Gloria
    Verma, Chandra
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2011, 79 (06) : 1715 - 1727
  • [9] Conformational changes in 2-trans-enoyl-ACP (CoA) reductase (InhA) from M. tuberculosis induced by an inorganic complex: a molecular dynamics simulation study
    André L. P. da Costa
    Ivani Pauli
    Márcio Dorn
    Evelyn K. Schroeder
    Chang-Guo Zhan
    Osmar Norberto de Souza
    Journal of Molecular Modeling, 2012, 18 : 1779 - 1790
  • [10] Conformational changes in 2-trans-enoyl-ACP (CoA) reductase (InhA) from M. tuberculosis induced by an inorganic complex: a molecular dynamics simulation study
    da Costa, Andre L. P.
    Pauli, Ivani
    Dorn, Marcio
    Schroeder, Evelyn K.
    Zhan, Chang-Guo
    de Souza, Osmar Norberto
    JOURNAL OF MOLECULAR MODELING, 2012, 18 (05) : 1779 - 1790